Menu
Back to User profile » Dr Nisana Namwat
Papers published by Dr Nisana Namwat:
In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
Dokduang H, Jamnongkarn W, Promraksa B, Suksawat M, Padthaisong S, Thanee M, Phetcharaburanin J, Namwat N, Sangkhamanon S, Titapun A, Khuntikeo N, Klanrit P, Loilome W
Drug Design, Development and Therapy 2020, 14:2319-2334
Published Date: 11 June 2020
Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway
Khophai S, Thanee M, Techasen A, Namwat N, Klanrit P, Titapun A, Jarearnrat A, Sa-Ngiamwibool P, Loilome W
OncoTargets and Therapy 2018, 11:7019-7029
Published Date: 16 October 2018
Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway
Daya M, Loilome W, Techasen A, Thanee M, Sa-Ngiamwibool P, Titapun A, Yongvanit P, Namwat N
OncoTargets and Therapy 2018, 11:395-408
Published Date: 18 January 2018
Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem
Hughes T, O'Connor T, Techasen A, Namwat N, Loilome W, Andrews RH, Khuntikeo N, Yongvanit P, Sithithaworn P, Taylor-Robinson SD
International Journal of General Medicine 2017, 10:227-237
Published Date: 10 August 2017